223 related articles for article (PubMed ID: 31536377)
1. Genome-bound enzymes as epigenetic drug targets in cancer.
Bomsztyk K; Wang Y
Epigenomics; 2019 Oct; 11(13):1463-1467. PubMed ID: 31536377
[No Abstract] [Full Text] [Related]
2. Epigenetic drugs take on cancer.
Kaiser J
Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
[No Abstract] [Full Text] [Related]
3. Targeting components of epigenome by small molecules.
You JS; Han JH
Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
[TBL] [Abstract][Full Text] [Related]
4. Cancer epigenetics: Moving forward.
Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic opportunities and challenges in cancer.
Best JD; Carey N
Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Regulation and Drug Discovery for Cancer Therapy.
Yu B; Ouyang L
Curr Top Med Chem; 2019; 19(12):971. PubMed ID: 31486748
[No Abstract] [Full Text] [Related]
9. Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381).
Lipka DB; Kuck D; Kliem C; Gerhauser C
Expert Opin Ther Pat; 2013 Apr; 23(4):537-43. PubMed ID: 23448241
[TBL] [Abstract][Full Text] [Related]
10. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
11. Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.
Song X; Xiong Y; Qi X; Tang W; Dai J; Gu Q; Li J
Mar Drugs; 2018 May; 16(5):. PubMed ID: 29786660
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic cancer therapy makes headway.
Mack GS
J Natl Cancer Inst; 2006 Oct; 98(20):1443-4. PubMed ID: 17047192
[No Abstract] [Full Text] [Related]
13. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
Santini V; Gozzini A; Ferrari G
Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
[TBL] [Abstract][Full Text] [Related]
15. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches on epigenetics.
Papait R; Monti E; Bonapace IM
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
[TBL] [Abstract][Full Text] [Related]
17. The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors.
Yang AS; Yang BJ
Epigenomics; 2016 Jan; 8(1):9-12. PubMed ID: 26698294
[No Abstract] [Full Text] [Related]
18. Epigenetic therapies reach main street.
Bates SE
Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089
[No Abstract] [Full Text] [Related]
19. Chemical inhibitors make their RNA epigenetic mark.
Cully M
Nat Rev Drug Discov; 2019 Nov; 18(12):892-894. PubMed ID: 31780844
[No Abstract] [Full Text] [Related]
20. The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy.
Liu N; Zhao R; Ma Y; Wang D; Yan C; Zhou D; Yin F; Li Z
Curr Top Med Chem; 2018; 18(28):2380-2394. PubMed ID: 30430946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
